Phase I Nicotinic Agonist Treatment Trial for Autism
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2016
Price : $35 *
At a glance
- Drugs GTS 21 (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 14 Jun 2016 Status changed from recruiting to discontinued due to reasons like difficult to find participants and no funding.
- 09 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
- 03 Dec 2014 Planned initiation date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov record.